Position in JNJ
as of Jun 30, 2026
· filed Jul 1, 2026
Position Value
$509,463
+$35,983 QoQ
Shares Held
2,006
+3.6% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.70%
of 13F equity value
Holder Rank
#3,688
of 4,676 holders
Holding Since
Dec 2022
15 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Global Wealth Strategies & Associates holds $1,240,903 across 3 Drug Manufacturers - General names. JNJ ranks #1 (41.1% of the industry book) .
All Filings in JNJ
Export CSV
15 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $509,463 | 2,006 | Shares | Sole | 2026-07-01 | |
| 2026-03-31 | $473,480 | 1,937 | Shares | Sole | 2026-04-03 | |
| 2025-12-31 | $398,999 | 1,928 | Shares | Sole | 2026-01-02 | |
| 2025-09-30 | $335,424 | 1,809 | Shares | Sole | 2025-10-02 | |
| 2025-06-30 | $257,994 | 1,689 | Shares | Sole | 2025-07-07 | |
| 2025-03-31 | $274,465 | 1,655 | Shares | Sole | 2025-04-02 | |
| 2024-12-31 | $98,341 | 680 | Shares | Sole | 2025-01-02 | |
| 2024-09-30 | $117,655 | 726 | Shares | Sole | 2024-10-01 | |
| 2024-06-30 | $101,435 | 694 | Shares | Sole | 2024-07-02 | |
| 2024-03-31 | $120,698 | 763 | Shares | Sole | 2024-04-01 | |
| 2023-12-31 | $119,592 | 763 | Shares | Sole | 2024-01-02 | |
| 2023-09-30 | $118,837 | 763 | Shares | Sole | 2023-10-20 | |
| 2023-06-30 | $130,098 | 786 | Shares | Sole | 2023-07-05 | |
| 2023-03-31 | $123,225 | 795 | Shares | Sole | 2023-04-03 | |
| 2022-12-31 | $140,436 | 795 | Shares | Sole | 2023-01-17 | |
| No filing history on record for this holder in this stock. | ||||||